Thermodynamic investigations on the inclusion complexation of piroxicam with cyclodextrin derivatives

Scientia Pharmaceutica

Volumn 73, Issue 3, 2005, Pages 147-161

  Charumanee, S ^a   Weiss Greiler, P ^b   Wolschann, P ^b   Viernstein, H ^b   Titwan, A ^a   Sirithunyalug, J ^a   Okonogi, S ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cyclodextrin; Inclusion complexation; Piroxicam; Reaction enthalpy; Reaction entropy; Solubility enhancement

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ANTIINFLAMMATORY AGENT; BETA CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; CAVAMAX W7; CAVAMAX W8; CAVASOL W7; CAVASOL W7M; CYCLODEXTRIN DERIVATIVE; GAMMA CYCLODEXTRIN; METHYL BETA CYLODEXTRIN; PIROXICAM; UNCLASSIFIED DRUG; WATER;

ABSORPTION SPECTROSCOPY; AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; CIRCULAR DICHROISM; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONFORMATIONAL TRANSITION; DISSOCIATION; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; DRUG TOLERABILITY; ELECTRIC POTENTIAL; ENTHALPY; ENTROPY; EQUILIBRIUM CONSTANT; FLUORESCENCE SPECTROSCOPY; GAS CHROMATOGRAPHY; HYDROPHOBICITY; LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARAMETER; PH; PHYSICAL CHEMISTRY; POTENTIOMETRIC TITRATION; TECHNIQUE; TEMPERATURE DEPENDENCE; THERMODYNAMICS;

EID: 27144471930     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.aut-05-13     Document Type: Article

References (32)

1. Loftsson, T. and Brewster, M.E. 1996. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. Journal of Pharmaceutical Sciences 85, 1017-1025.
2. Hedges, R.A. 1998. Industrial applications of cyclodextrins. Chemical Review 98, 2035-2044.
3. Mamata, S., Rohit, S. and Banerju, U.C. 2002. Biotechnological applications of cyclodextrins. Biotechnology Advances 20, 341-359.
4. Uekama, K. 2002. Recent aspects of pharmaceutical applications of cyclodextrins. Journal of Inclusion Phenomena and Macrocyclic Chemistry 44, 3-7.
5. Irie, T. and Uekama, K. 1997. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. Journal of Pharmaceutical Sciences 86, 147-162.
6. 13C nuclear magnetic resonance spectra of azo dyes and their complexes with cyclomalto-oligosaccharides. Carbohydrate Research 288, 75-84.
7. Gezawi, El S., Omar, N., Rabbat, El N., Ueda, H. and Perrin, J.H. 1988. Microcalorimetric and chromatographic investigations of the binding of some pyridine derivatives to cyclodextrins. Journal of Pharmaceutical and Biomedical Analysis 6, 399-406.
8. Braibanti, A., Fisicaro, E., Ghiozzi, A., Compari, C. and Bovis, G. 1998. Host-guest interactions between β-cyclodextrin and piroxicam. Reactive&Functional Polymers 36, 251-255.
9. Dalmora, M.E.A. and Oliveira, A.G. 1999. Inclusion complex of piroxicam with β-cyclodextrin and incorporation in hexadecyltrimethylammonium bromide based microemulsion. International Journal of Pharmaceutics 184, 157-164.
10. Yang, C., Lui, L., Mu, T-W and Quo, Q-W. 2001. Improved accuracy and efficiency in the determination of association constants with spectrophotometric method. Journal of Inclusion Phenomena and Macrocyclic Chemistry 39, 97-101.
11. Matsubara, K., Irie, T. and Uekama, K. 1997. Spectroscopic characterization of the inclusion complex of a luteinizing hormone-releasing hormone agonist, Buserelin acetate, with dimethyl-β-cyclodextrin. Chemical Pharmaceutical Bulletin 45, 378-383.
12. Marconi, G., Monti, S., Manoli, F. Esposti, A.D. and Mayer, B. 2004. A circular dichroism and structural study of the inclusion complex artemisinin-β-cyclodextrin. Chemical Physics Letters 383, 566-571.
13. Escandar, G.M. 1999. Spectrofluorometric determination of piroxicam in the presence and absence of β-cyclodextrin. Analyst 124, 587-591.
14. Ma, L., Tang, B., and Chu, C. 2002. Spectrofluorometric study of the β-cyclodextrin-dapsone-linear alcohol supramolecular system and determination of dapsone. Analytica Chimica Acta 469, 273-283.
15. Xiliang, G. Yu, Y., Guoyan, Z., Guomei, Z., Jianbin, C. and Shaomin, S. 2003. Study on inclusion interaction of piroxicam with β-cyclodextrin derivatives. Spectrochimica Acta Part A 59, 3379-3386.
16. Rozou, S., Voulgari, A. and Antoniadou-Vyza, E. 2004. The effect of pH dependent molecular conformation and dimerization phenomena of piroxicam on the drug: cyclodextrin complex stoichiometry and its chromatographic behavior: A new specific HPLC method for piroxicam:cyclodextrin formulations. European Journal of Pharmaceutical Sciences 21, 661-669.
17. Junquera, E., Ruiz, D. and Aicart, A. 1999. Role of hydrophobic effect on the noncovalent interaction between salicylic acid and a series of β-cyclodextrin. Journal of Colloid and Interface Science 216, 154-160.
18. Masson, M., Loftsson, T., Jonsdottir, S., Fridriksdottir, H. and Petersen, D.S. 1998. Stabilisation of ionic drugs through complexation with non-ionic and ionic cyclodextrins. International Journal of Pharmaceutics 164, 45-55.
19. Walker, R.B., Dholakia, V.N., Brasfield, K.L. and Bakhtiar, R. 1998. Effect of Hydroxypropyl-β-cyclodextrin on the central stimulant activity of (-)- Ephedrine and an oxazolidine prodrug in rats. Gen. Pharmaco. 30, 725-731.
20. Jug, M. and Becirevic-Lacan, M. 2004. Influence of hydroxypropyl-β- cyclodextrin complexation on piroxicam release from buccoadhesive tablets. European Journal of Pharmaceutical Sciences 21, 251-260.
21. Saetern, A.M., Nguyen, N.B., Bauer-Brandl, A. and Brandi, M. 2004. Effect of hydroxypropyl-β-cyclodextrin complexation and pH on solubility of camptothecin. International Journal of Pharmaceutics 284, 61-68.
22. Viernstein, H., Weiß-Greiler P. and Wolschann P. 2002. Solubility Enhancement of Low Soluble Biologically Active Compounds by β-Cyclodextrin and Dimethyl-β-cyclodextrin. Journal of Inclusion Phenomena and Macrocyclic Chemistry 44, 235-239.
23. Santucci, L., Fiorucci, S., Chiucchiu, S., Sicilia, A. Bufalino, L., Morelli, A. and Policlin, M. 1992. Placebo-controlled comparison of piroxicam-β-cyclodextrin, piroxicam and indomethacin on gastric potential difference and mucosal injury in humans. Digestive Disease and Science 37, 1825-1832.
24. Woodcock, B.G., Acerbi, D., Merz, P.G., Rietbrock, S. and Rietbrock, N. 1993. Supermolecular inclusion of piroxicam with β-cyclodextrin: pharmacokinetic properties in man. European Journal of rheumatology and inflammation 12, 12-28.
25. Deroubaix, X., Stockis, A. Allemon, A.M. Lebacq, E., Acerbi, D. and Ventura, P. 1995. Oral bioavailability of CHF 1194, an inclusion complex of piroxicam and β-cyclodextrin, in healthy subjects under single dose and steady-state conditions. European Journal of Clinical Pharmacology 47, 531-536.
26. Tsai, R.S., Carrupt, P-A., El Tayar, N., Giroud, Y., Andrade, P., Testa, B., Bree, F., and Tillement, J.P. 1993. Physicochemical and structural properties of nonsteroidal anti-inflammatory oxicams. Helvetica Chimica Acta 76, 842-854.
27. Higuchi, T. and Connors, K.A. 1965. Phase solubility techniques. In: Reilley, C.N. (ed.), Advances in Analytical Chemistry and Instrumentation, Volume 4. Interscience, New York, 117-212.
28. Saarinen-Savolainen, P., Urtti, A., Jarho, P. and Jarvinen, T. 1997. β-cyclodextrin derivatives (2-HP-β-CD, SBE4-β-CD) decrease the amphiphilicity and membrane perturbing effects of pilocarpine prodrugs. European Journal of Pharmaceutical Sciences 5, 89-96.
29. Jarho, P., Urtti, A., Pate, D.W., Suhonen, P. and Jarviner, T. 1996. Increase in aqueous solubility, stability and in vitro corneal permeability of anandamide by hydroxypropyl-cylcodextrin. International Journal of Pharmaceutics 137, 209-216.
30. Nagase, Y., Hirata, M., Wada, K., Arima, H., Hirayama, F., Irie, T., Kikuchi, M. and Uekama, K. 2001. Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether β-cyclodextrin. International Journal of Pharmaceutics 229, 163-172.
31. Layre, A.M., Gosselet, N.M., Renard, E., Sebille, B. and Amiel, C. 2002. Comparison of the complexation of cosmetical and pharmaceutical compounds with γ-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and water-soluble β-cyclodextrin-co-epichlorhydrin polymers. Journal of Inclusion Phenomena and Macrocyclic Chemistry 43, 311-317.
32. Rekharsky, M.V. and Inoue, Y. 1998. Complexation Thermodynamic of cyclodextrins. Chemical Review 98, 1875-1917.